![Benjamin Hickey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benjamin Hickey
President at
RAYZEBIO, INC.
Net worth: 960 641 $ as of 29/06/2026
Profile
Benjamin Joseph Hickey is Director at Bristol-Myers Squibb Holdings 2002 Ltd. since 2016 and President at Rayzebio, Inc. since 2024.
Former roles include Independent Director at Surface Oncology, Inc. from 2021 to 2023, Director at Bristol-Myers Squibb Pharmaceuticals Ltd. from 2016 to 2018, Independent Director at Mural Oncology Plc from 2023 to 2025, Chief Commercial Officer & Senior Vice President at Halozyme Therapeutics, Inc. from 2018 to 2020, Chief Commercial Officer at Mirati Therapeutics, Inc. from 2020 to 2024, and Vice President-Marketing at Bristol Myers Squibb Co. from 2014 to 2016.
Education includes undergraduate and MBA degrees from St. John's University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 09/03/2026 | 16,672 ( 0% ) | 960 641 $ | 29/06/2026 |
Benjamin Hickey active positions
| Companies | Position | Start |
|---|---|---|
| RAYZEBIO, INC. | President | 25/02/2024 |
Bristol-Myers Squibb Holdings 2002 Ltd.
 Bristol-Myers Squibb Holdings 2002 Ltd. Medical DistributorsDistribution Services Operates as a holding company whose subsidiaries distributes and sells pharmaceutical products | Director/Board Member | 31/07/2016 |
Former positions of Benjamin Hickey
| Companies | Position | End |
|---|---|---|
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 22/01/2024 |
| SURFACE ONCOLOGY, INC. | Director/Board Member | 07/09/2023 |
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 31/12/2019 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 02/09/2018 |
Training of Benjamin Hickey
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
St. John's University
 St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb Holdings 2002 Ltd.
Bristol-Myers Squibb Holdings 2002 Ltd. Medical DistributorsDistribution Services Operates as a holding company whose subsidiaries distributes and sells pharmaceutical products | Distribution Services |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Benjamin Hickey
